NCT06830603

Brief Summary

This prospective clinical study aims at evaluating clinical, radiographic, patient-reported outcomes of total knee arthroplasty with Physica TT Tibial Plate over 2 years after surgery, in order to assess the performance and safety of the devices. Short-term survivorship of the implant and the incidence of early complications are evaluated.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for all trials

Timeline
32mo left

Started May 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
May 2025Dec 2028

First Submitted

Initial submission to the registry

February 11, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 17, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

February 17, 2025

Status Verified

February 1, 2025

Enrollment Period

3.6 years

First QC Date

February 11, 2025

Last Update Submit

February 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Knee Society Score from preoperative to 2 years after surgery

    0-100 scale. Scores rating from 80 to 100 are considered excellent, between 70 and 79 good, between 60 and 69 fair, and less than 60 poor

    From preoperative to 2 years after surgery

Secondary Outcomes (5)

  • Change in Oxford Knee Score

    From preoperative to 2 years after surgery

  • Change in Range of Motion

    From preoperative to 2 years after surgery

  • Radiographic implant evaluation and stability assessment

    From preoperative to 2 years after surgery

  • Incidence, type and severity of Adverse Device Effects (ADE) and Serious Adverse Device Effects (SADE)

    From preoperative to 2 years after surgery

  • Implant survival rate

    From preoperative to 2 years after surgery

Study Arms (1)

Physica TT Tibial Plate

Total knee arthroplasty with Physica TT Tibial Plate

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

General population of subjects requiring a primary TKR with a diagnosis of painful primary or secondary osteoartrithis not responding to other conservative treatments, after the review of medical history and the radiographic evaluation of the affected knee.

You may qualify if:

  • Patient requiring a total knee arthroplasty (TKA) and suitable for receiving Physica TT Tibial Plate;
  • Age ≥ 18 years old;
  • Candidate for primary total knee replacement when clinical indications based on physical examination and medical history include one or more of the following conditions:
  • Non-inflammatory degenerative joint disease such as knee osteoarthritis, post traumatic knee arthritis;
  • Inflammatory degenerative joint disease such as rheumatoid arthritis;
  • Patient has well-preserved and well-functioning collateral ligaments
  • Patient is able to understand the conditions of the study, is willing and able to follow all prescribed rehabilitation as well as willing to perform all scheduled follow-up visits;
  • Patient has signed the study-specific Informed Consent Form prior to study activities

You may not qualify if:

  • Patient is affected by one or more of the conditions that are stated as Physica contraindications for use, which are:
  • Severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function.
  • Any active or suspected infection (local or systemic) or previous history of infection that may affect the prosthetic joint.
  • Significant bone loss on femoral or tibial joint side.
  • Known incompatibility or allergy to the product materials, and/or metal hypersensitivity to implant materials.
  • Septicaemia.
  • Persistent acute or chronic osteomyelitis.
  • Open epiphyses (immature patient with active bone growth).
  • Necrotic bone
  • Arterial vascular insufficiency or nerve diseases of the lower limbs severe enough to interfere with the study evaluation.
  • Compromised bone stock due to disease, infection or prior implantation that cannot provide adequate support and/or fixation to the prosthesis.
  • Systemic or metabolic disorders leading to progressive bone deterioration, which may impair fixation and stability of the implant.
  • Any concomitant disease and dependency that might affect the performance of the implanted prosthesis.
  • Important osteoporosis, haemophilic disease.
  • Internistic problems with high risk for surgery.
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Central Study Contacts

Francesca Citossi

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2025

First Posted

February 17, 2025

Study Start

May 1, 2025

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

February 17, 2025

Record last verified: 2025-02